K. Ogasawara, J. Hamerman, H. Hsin, S. Chikuma, Hélène Bour-Jordan, Taian Chen, Thomas Pertel, C. Carnaud, J. Bluestone, L. Lanier (2003)
Impairment of NK cell function by NKG2D modulation in NOD mice.Immunity, 18 1
C. Schmitt, J. Fridman, Meng Yang, Soyoung Lee, E. Baranov, R. Hoffman, S. Lowe (2002)
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer TherapyCell, 109
Raju Pusapati, R. Rounbehler, Sungki Hong, John Powers, Mingshan Yan, K. Kiguchi, M. McArthur, P. Wong, David Johnson (2006)
ATM promotes apoptosis and suppresses tumorigenesis in response to MycProceedings of the National Academy of Sciences of the United States of America, 103
Clemens Schmitt, M. McCurrach, E. Stanchina, R. Wallace-Brodeur, Scott Lowe (1999)
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.Genes & development, 13 20
C. Sherr (2001)
The INK4a/ARF network in tumour suppressionNature Reviews Molecular Cell Biology, 2
W. Yokoyama, B. Plougastel (2003)
Immune functions encoded by the natural killer gene complexNature Reviews Immunology, 3
J. Nilsson, U. Keller, T. Baudino, Chunying Yang, S. Norton, Jennifer Old, L. Nilsson, G. Neale, D. Kramer, C. Porter, J. Cleveland (2005)
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.Cancer cell, 7 5
A. Diefenbach, A. Jamieson, Scot Liu, N. Shastri, D. Raulet (2000)
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophagesNature Immunology, 1
A. Cerwenka, L. Lanier (2001)
Natural killer cells, viruses and cancerNature Reviews Immunology, 1
D. Raulet (2003)
Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 3
A. Diefenbach, Eric Jensen, A. Jamieson, D. Raulet (2001)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunityNature, 413
Y. Hayakawa, J. Kelly, J. Westwood, P. Darcy, A. Diefenbach, D. Raulet, M. Smyth (2002)
Cutting Edge: Tumor Rejection Mediated by NKG2D Receptor-Ligand Interaction Is Dependent upon Perforin1The Journal of Immunology, 169
G. Evan, K. Vousden (2001)
Proliferation, cell cycle and apoptosis in cancerNature, 411
J. Routes, S. Ryan, K. Morris, Rayna Takaki, A. Cerwenka, L. Lanier (2005)
Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejectionThe Journal of Experimental Medicine, 202
A. Jamieson, A. Diefenbach, C. Mcmahon, N. Xiong, J. Carlyle, D. Raulet (2002)
The role of the NKG2D immunoreceptor in immune cell activation and natural killing.Immunity, 17 1
O. Vafa, M. Wade, S. Kern, M. Beeche, T. Pandita, G. Hampton, G. Wahl (2002)
c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability.Molecular cell, 9 5
M. Serrano, Han-Woong Lee, L. Chin, C. Cordon-Cardo, D. Beach, R. DePinho (1996)
Role of the INK4a Locus in Tumor Suppression and Cell MortalityCell, 85
C. Eischen, J. Weber, M. Roussel, C. Sherr, J. Cleveland (1999)
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.Genes & development, 13 20
S. Frank, M. Schroeder, P. Fernandez, S. Taubert, B. Amati (2001)
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.Genes & development, 15 16
E. Fearon, B. Vogelstein (1990)
A genetic model for colorectal tumorigenesisCell, 61
(2005)
Cancer Cell 7:433–444
(1996)
Proc Natl Acad Sci USA
A. Cerwenka, Alexander Bakker, Terri McClanahan, Janet Wagner, Jun Wu, Joseph Phillips, Lewis Lanier (2000)
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.Immunity, 12 6
(1999)
Genes Dev
A. Cerwenka, J. Baron, L. Lanier (2001)
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivoProceedings of the National Academy of Sciences of the United States of America, 98
N. Hastie (1999)
Introduction of Suzanne CoryCancer Research, 59
A. Harris, Carl Pinkert, Marjorie Crawford, Wallace Langdon, Ralph Brinster, J. Adams (1988)
The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cellsThe Journal of Experimental Medicine, 167
S. Shreeram, Weng Hee, O. Demidov, Calvina Kek, H. Yamaguchi, A. Fornace, C. Anderson, E. Appella, D. Bulavin (2006)
Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphataseThe Journal of Experimental Medicine, 203
M. Lodoen, K. Ogasawara, J. Hamerman, H. Arase, J. Houchins, E. Mocarski, L. Lanier (2003)
NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene MoleculesThe Journal of Experimental Medicine, 197
M. Girardi, D. Oppenheim, C. Steele, Julia Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R. Tigelaar, A. Hayday (2001)
Regulation of Cutaneous Malignancy by γδ T CellsScience, 294
D. Jacobs, D. Glossip, H. Xing, Anthony Muslin, K. Kornfeld (1999)
Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase.Genes & development, 13 2
W. Langdon, A. Harris, S. Cory, Jerry Adams (1986)
The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic miceCell, 47
E. Guccione, Francesca Martinato, G. Finocchiaro, L. Luzi, L. Tizzoni, Valentina Olio, G. Zardo, C. Nervi, L. Bernard, B. Amati (2006)
Myc-binding-site recognition in the human genome is determined by chromatin contextNature Cell Biology, 8
V. Gorgoulis, L. Vassiliou, Panagiotis Karakaidos, Panayotis Zacharatos, A. Kotsinas, T. Liloglou, M. Venere, R. DiTullio, N. Kastrinakis, B. Levy, D. Kletsas, A. Yoneta, M. Herlyn, C. Kittas, T. Halazonetis (2005)
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 434
S. Gasser, S. Orsulic, E. Brown, D. Raulet (2005)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptorNature, 436
V. Groh, Jennifer Wu, C. Yee, T. Spies (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activationNature, 419
B. Hsu, M. Marin, A. El-Naggar, L. Stephens, S. Brisbay, T. McDonnell (1995)
Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.Oncogene, 11 1
É. Vivier, J. Nunès, F. Vely (2004)
Natural Killer Cell Signaling PathwaysScience, 306
S. Lowe, E. Cepero, G. Evan (2004)
Intrinsic tumour suppressionNature, 432
Jerry Adams, A. Harris, C. Pinkert, L. Corcoran, W. Alexander, S. Cory, R. Palmiter, R. Brinster (1985)
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 318
A. Egle, A. Harris, M. Bath, L. O’Reilly, S. Cory (2004)
VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.Blood, 103 6
F. Zindy, C. Eischen, D. Randle, T. Kamijo, J. Cleveland, C. Sherr, M. Roussel (1998)
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.Genes & development, 12 15
J. Bártková, Z. Hořejší, K. Koed, A. Krämer, F. Tort, K. Zieger, P. Guldberg, M. Sehested, J. Nesland, C. Lukas, T. Ørntoft, J. Lukas, J. Bartek (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 434
D. Cosman, J. Müllberg, Claire Sutherland, Wilson Chin, R. Armitage, W. Fanslow, M. Kubin, N. Chalupny (2001)
ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.Immunity, 14 2
Suma Ray, K. Atkuri, Debabrita Deb-Basu, A. Adler, Howard Chang, L. Herzenberg, D. Felsher (2006)
MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species.Cancer research, 66 13
R. Medzhitov, C. Janeway (2002)
Decoding the Patterns of Self and Nonself by the Innate Immune SystemScience, 296
V. Groh, S. Bahram, S. Bauer, A. Herman, M. Beauchamp, T. Spies (1996)
Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.Proceedings of the National Academy of Sciences of the United States of America, 93 22
M. Smyth, J. Swann, E. Cretney, N. Zerafa, W. Yokoyama, Y. Hayakawa (2005)
NKG2D function protects the host from tumor initiationThe Journal of Experimental Medicine, 202
S. Bauer, V. Groh, Jun-ying Wu, A. Steinle, J. Phillips, L. Lanier, T. Spies (1999)
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.Science, 285 5428
Proceedings of the National Academy of Sciences – Unpaywall
Published: Jan 26, 2008
Access the full text.
Sign up today, get DeepDyve free for 14 days.